Nasdaq: ACXP

Acurx Pharmaceuticals, Inc. (ACXP)

Acurx Pharmaceuticals, Inc. is a public company that reports to the U.S. Securities and Exchange Commission and trades on Nasdaq under the ticker ACXP. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
ACXP
Exchange
Nasdaq
SEC CIK
1736243
Official filings
SEC EDGAR

Research ACXP

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is Acurx Pharmaceuticals, Inc.'s stock ticker?

Acurx Pharmaceuticals, Inc. trades under the ticker symbol ACXP on Nasdaq. Its SEC Central Index Key (CIK) is 1736243.

Where can I read Acurx Pharmaceuticals, Inc.'s SEC filings?

The ACXP SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports Acurx Pharmaceuticals, Inc. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze ACXP's financial statements?

The ACXP Financials page shows Acurx Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does ACXP compare with its peers and the market?

The ACXP Peer Comparison page lines Acurx Pharmaceuticals, Inc. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.